ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /化合物

フマル酸/鉄(II),(1:x)

Ferrous Fumarate

HCID 6433164
ノートを作成反応を作成見積依頼を出す
印刷プレビュー
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
141-01-5
標準SMILES
O=C([O-])/C=C/C(=O)[O-].[Fe+2]
InChIKey
PMVSDNDAUGGCCE-TYYBGVCCSA-L
分子式
C4H2FeO4
平均分子量
169.9 g/mol
単同位体質量
169.930244

概要

Ferrous fumarate is a dicarboxylic acid.

名称と識別子

優先名称
Ferrous Fumarate
IUPAC
(E)-but-2-enedioate;iron(2+)
現地名
フマル酸/鉄(II),(1:x)
英語名
Fumaric acid/iron(II),(1:x) salt
分子式
C4H4FeO4
分子量
171.92

名称と別名

Ferrous fumarateIron(II) fumarate141-01-5FeostatErcoferroFerrofumeTolferainCpironHemotonPalaferToleronTolifer
名称をさらに表示
フマル酸/鉄(II),(1:x)Einecs 231-731-5Fumaric acid/iron(II),(1:x) salt2-Butenedioic acid (2E)-, iron(2+) salt (1:)
GalferIrconErco-FerFumar2-Butenedioic acid (2E)-, iron(2+) salt (1:1)HeferolOrgasalFUMARIC ACID, IRON(2+) SALT (1:1)

データベース識別子

CAS
141-01-5、7705-12-6
PubChem CID
6433164
DTXSID
DTXSID7047148
ChEMBL
CHEMBL1200640
ChEBI
CHEBI:31607
UNII
R5L488RY0Q
EC Number
205-447-7、231-731-5

物性

構造計算による物性

極性表面積
80.3 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
0
重原子数
9
形式電荷
0
複雑度
108

実験および物理化学的性質

CosmeticsCosmetic ingredients (Ferrous Fumarate) -> CIR (Cosmetic Ingredient Review)
Food AdditivesNUTRIENT SUPPLEMENT -> FDA Substance added to food
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionDry Powder

物理化学的性質

EPAの化学物質情報
2 · 2-Butenedioic acid (2E)-, iron(2+) salt (7705-12-6)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

This chemical does not meet GHS hazard criteria for 47% (93 of 198) of reports.

H412 (53%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]

P273, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 198 reports by companies from 2 notifications to the ECHA C&L Inventory.

This chemical does not meet GHS hazard criteria for 100% (36 of 36) of all reports.

Not Classified

危険有害性情報

Regulatory Information · 6 件

Chemical: 2-Butenedioic acid, (E)-, iron(2+) salt (1:1)

Chemical: 2-Butenedioic acid, (E)-, iron(2+) salt

Regulation (EC) No 1831/2003 (amended)

2-Butenedioic acid (2E)-, iron(2+) salt (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 2-Butenedioic acid (2E)-, iron(2+) salt (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: Iron(II) fumarate (EC: 205-447-7)

Ferrous fumarate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety Information · 2 件

Evaluation - Chemicals that are unlikely to require further regulation to manage risks to human health

Evaluation - Chemicals that are unlikely to require further regulation to manage risks to human health

Hazard Classes and Categories · 2 件

Aquatic Chronic 3 (53%)

Not Classified

毒性情報

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

安全データ

tsca
TSCA listed

化学と産業

薬理情報

ATC Code · 2 件

B - Blood and blood forming organs

QB - Blood and blood forming organs

PharmacodynamicsThe major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Mechanism of ActionIron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
MeSH Pharmacological ClassificationA group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Absorption, Distribution and Excretion · 1 件

The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.

用途と製造

UsesCIR ingredient: Ferrous Fumarate
U.S. Production2023: 1,837 lb
Industry UsesIntermediate
General Manufacturing Information · 3 件

All Other Basic Inorganic Chemical Manufacturing

2-Butenedioic acid (2E)-, iron(2+) salt (1:1): ACTIVE

2-Butenedioic acid (2E)-, iron(2+) salt (1:?): INACTIVE

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
その他の操作
ノートを作成反応を作成見積依頼を出す